UniProt ID | NEK6_HUMAN | |
---|---|---|
UniProt AC | Q9HC98 | |
Protein Name | Serine/threonine-protein kinase Nek6 | |
Gene Name | NEK6 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 313 | |
Subcellular Localization | Cytoplasm. Nucleus. Nucleus speckle. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome. Cytoplasm, cytoskeleton, spindle pole. Colocalizes with APBB1 at the nuclear speckles. Colocalizes with PIN1 in the nucleus. Colocalizes with ATF | |
Protein Description | Protein kinase which plays an important role in mitotic cell cycle progression. Required for chromosome segregation at metaphase-anaphase transition, robust mitotic spindle formation and cytokinesis. Phosphorylates ATF4, CIR1, PTN, RAD26L, RBBP6, RPS7, RPS6KB1, TRIP4, STAT3 and histones H1 and H3. Phosphorylates KIF11 to promote mitotic spindle formation. Involved in G2/M phase cell cycle arrest induced by DNA damage. Inhibition of activity results in apoptosis. May contribute to tumorigenesis by suppressing p53/TP53-induced cancer cell senescence.. | |
Protein Sequence | MAGQPGHMPHGGSSNNLCHTLGPVHPPDPQRHPNTLSFRCSLADFQIEKKIGRGQFSEVYKATCLLDRKTVALKKVQIFEMMDAKARQDCVKEIGLLKQLNHPNIIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSETTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPGEHYSEKLRELVSMCICPDPHQRPDIGYVHQVAKQMHIWMSST | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MAGQPGHM -------CCCCCCCC | 9.49 | - | |
13 | Phosphorylation | GHMPHGGSSNNLCHT CCCCCCCCCCCCCCC | 34.19 | 30108239 | |
14 | Phosphorylation | HMPHGGSSNNLCHTL CCCCCCCCCCCCCCC | 32.77 | 28857561 | |
20 | Phosphorylation | SSNNLCHTLGPVHPP CCCCCCCCCCCCCCC | 32.20 | 28857561 | |
35 | Phosphorylation | DPQRHPNTLSFRCSL CCCCCCCCEEEEEEH | 28.38 | 30108239 | |
37 | Phosphorylation | QRHPNTLSFRCSLAD CCCCCCEEEEEEHHH | 14.49 | 30108239 | |
41 | Phosphorylation | NTLSFRCSLADFQIE CCEEEEEEHHHHHHH | 23.49 | 27251275 | |
49 | Ubiquitination | LADFQIEKKIGRGQF HHHHHHHHHHCCCCC | 51.85 | - | |
57 | Phosphorylation | KIGRGQFSEVYKATC HHCCCCCHHHHHHHH | 20.47 | 26074081 | |
60 | Phosphorylation | RGQFSEVYKATCLLD CCCCHHHHHHHHHHC | 7.28 | 26074081 | |
61 | Ubiquitination | GQFSEVYKATCLLDR CCCHHHHHHHHHHCC | 42.25 | - | |
63 | Phosphorylation | FSEVYKATCLLDRKT CHHHHHHHHHHCCCE | 10.26 | 26074081 | |
75 | Phosphorylation | RKTVALKKVQIFEMM CCEEEEEEEHHHHHC | 39.98 | 27251275 | |
85 | Ubiquitination | IFEMMDAKARQDCVK HHHHCCHHHHHHHHH | 39.58 | - | |
92 | Ubiquitination | KARQDCVKEIGLLKQ HHHHHHHHHHHHHHH | 50.36 | - | |
98 | Ubiquitination | VKEIGLLKQLNHPNI HHHHHHHHHCCCCCH | 58.75 | - | |
108 | Phosphorylation | NHPNIIKYLDSFIED CCCCHHHHHHHHHHC | 12.82 | 19941817 | |
152 | Phosphorylation | PERTVWKYFVQLCSA CHHHHHHHHHHHHHH | 8.02 | - | |
158 | Phosphorylation | KYFVQLCSAVEHMHS HHHHHHHHHHHHHHH | 43.89 | - | |
165 | Phosphorylation | SAVEHMHSRRVMHRD HHHHHHHHCCCCCCC | 17.76 | - | |
174 | Ubiquitination | RVMHRDIKPANVFIT CCCCCCCCCCCEEEE | 42.22 | 21890473 | |
181 | Phosphorylation | KPANVFITATGVVKL CCCCEEEEECEEEEE | 13.50 | - | |
183 | Phosphorylation | ANVFITATGVVKLGD CCEEEEECEEEEECC | 23.12 | - | |
187 | Ubiquitination | ITATGVVKLGDLGLG EEECEEEEECCCCCC | 44.33 | - | |
198 | Phosphorylation | LGLGRFFSSETTAAH CCCCCCCCCCCHHHH | 25.26 | 22115753 | |
199 | Ubiquitination | GLGRFFSSETTAAHS CCCCCCCCCCHHHHH | 33.53 | 21890473 | |
199 | Phosphorylation | GLGRFFSSETTAAHS CCCCCCCCCCHHHHH | 33.53 | 21712546 | |
201 | Phosphorylation | GRFFSSETTAAHSLV CCCCCCCCHHHHHCC | 24.55 | 21945579 | |
202 | Phosphorylation | RFFSSETTAAHSLVG CCCCCCCHHHHHCCC | 20.14 | 21945579 | |
206 | Phosphorylation | SETTAAHSLVGTPYY CCCHHHHHCCCCCCC | 21.74 | 21945579 | |
208 (in isoform 2) | Ubiquitination | - | 10.07 | - | |
210 | Phosphorylation | AAHSLVGTPYYMSPE HHHHCCCCCCCCCHH | 10.71 | 21945579 | |
212 | Phosphorylation | HSLVGTPYYMSPERI HHCCCCCCCCCHHHH | 16.19 | 21945579 | |
213 | Phosphorylation | SLVGTPYYMSPERIH HCCCCCCCCCHHHHH | 7.72 | 21945579 | |
215 | Phosphorylation | VGTPYYMSPERIHEN CCCCCCCCHHHHHHC | 13.90 | 21945579 | |
224 | Phosphorylation | ERIHENGYNFKSDIW HHHHHCCCCCHHHHH | 29.07 | 29496907 | |
235 | Phosphorylation | SDIWSLGCLLYEMAA HHHHHHHHHHHHHHH | 2.61 | 27251275 | |
236 | Phosphorylation | DIWSLGCLLYEMAAL HHHHHHHHHHHHHHH | 5.60 | 27251275 | |
240 | Phosphorylation | LGCLLYEMAALQSPF HHHHHHHHHHHHCCC | 1.34 | 27251275 | |
277 | Ubiquitination | PGEHYSEKLRELVSM CCCCCHHHHHHHHHH | 47.07 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
206 | S | Phosphorylation | Kinase | NEK9 | Q8TD19 | Uniprot |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NEK6_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Characterization of hNek6 interactome reveals an important role forits short N-terminal domain and colocalization with proteins at thecentrosome."; Vaz Meirelles G., Ferreira Lanza D.C., da Silva J.C.,Santana Bernachi J., Paes Leme A.F., Kobarg J.; J. Proteome Res. 9:6298-6316(2010). Cited for: FUNCTION, INTERACTION WITH ANKRA2; ATF4; ARHGAP33; CDC42; CIR1; NEK9;PRAM1; PTN; PRDX3; RAD26L; RBBP6; RPS7 AND TRIP4, PHOSPHORYLATION ATSER-206, AND AUTOPHOSPHORYLATION. | |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-206, AND MASSSPECTROMETRY. | |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-35; SER-198; SER-199;THR-201; THR-202 AND SER-206, AND MASS SPECTROMETRY. | |
"A mitotic cascade of NIMA family kinases. Nercc1/Nek9 activates theNek6 and Nek7 kinases."; Belham C., Roig J., Caldwell J.A., Aoyama Y., Kemp B.E., Comb M.,Avruch J.; J. Biol. Chem. 278:34897-34909(2003). Cited for: PHOSPHORYLATION AT SER-37; THR-202 AND SER-206. | |
"Human NIMA-related kinase 6 is one of the Fe65 WW domain bindingproteins."; Lee E.J., Hyun S.H., Chun J., Kang S.S.; Biochem. Biophys. Res. Commun. 358:783-788(2007). Cited for: SUBCELLULAR LOCATION, INTERACTION WITH APBB1, AND PHOSPHORYLATION ATTHR-210. |